Clinical course of asymptomatic patients with carotid duplex scan end diastolic velocities of 100 to 124 centimeters per second  by Riles, Thomas S. et al.
From the Society for Vascular Surgery
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Caron B. Rockman, MD, New York, NY
Objective: With the decline of diagnostic angiography, clinicians increasingly rely upon duplex scan criteria to select
appropriate asymptomatic candidates for carotid intervention. Some recent trials have enrolled patients for intervention
based upon end diastolic velocities (EDVs) as low as 100 cm/second, and peak systolic velocities (PSVs) as low as 230
cm/second. In as much as we have used more selective duplex scan criteria, we reviewed the course of asymptomatic
patients who had EDVs from 100 to 124 cm/second.
Methods: Of the patients evaluated in our Intersocietal Commission for the Accreditation of Vascular Laboratories
(ICAVL) accredited laboratory from 2002 to 2007, 144 patients had an EDV 100 to 124 cm/second. Of these, 47
patients underwent initial carotid intervention for concomitant symptoms (10), contralateral occlusion (3), or other
imaging findings felt to warrant intervention. The remaining 97 asymptomatic patients were followed. One patient had
both arteries fall within this EDV range. The mean follow-up for the 98 arteries was 29.1 months (range, 2-116months).
Results: Five patients (5.2%) developed ipsilateral symptoms consisting of one stroke and four transient ischemic attacks
(TIAs), at a mean time of 35.3 months (range, 12-58 months). Twenty-six patients (26.8%), including 3 who also
developed ipsilateral symptoms, progressed to having an EDV of >125 cm/second at a mean time of 24 months (range,
2-58). Two of these (2.1%) progressed directly to occlusion without symptoms and with no documented interim
worsening of stenosis.
Conclusion: For asymptomatic individuals with an initial EDV of 100 to 124 cm/second, the risk of ipsilateral stroke is
small and, therefore, medical management is appropriate in most cases. However, the risk of progression to a more severe
degree of stenosis, often warranting carotid intervention, is clinically meaningful. Yearly duplex scan follow-up is
necessary to assess disease progression in this patient cohort. ( J Vasc Surg 2010;52:914-9.)The rationale for performing carotid endarterectomy
on patients with carotid bifurcation disease is based on
level I data from multi-center randomized, prospective
trials comparing medical and surgical therapy (the North
American Symptomatic Carotid Endarterectomy Trial
[NASCET]1 and the Asymptomatic Carotid Atherosclero-
sis Study [ACAS]2). Entry into these trials was based on the
calculated maximum degree of stenosis at the plaque as
measured by digital subtraction angiography; which was
measured by calculating the residual lumen diameter at the
location of maximal stenosis, compared to the lumen diam-
eter of a more distal “normal” segment of the internal
carotid artery. Today, in most clinical settings, duplex
scanning has replaced conventional angiography in the
initial evaluation of patients suspected of having carotid
From the New York University Langone Medical Center.
Competition of interest: none.
Presented at the 2009 Vascular Annual Meeting, June 11-14, 2009, Denver,
Colo.
Additional material for this article may be found online at www.jvascsurg.
org.
Reprint requests: Thomas S. Riles, MD, New York University Medical
Center, 530 First Avenue, Suite 6F, New York, NY 10016 (e-mail:
thomas.riles@med.nyu.edu).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00
Copyright © 2010 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2010.05.016
914bifurcation disease. The duplex scan is often supplemented
with either magnetic resonance angiography (MRA) or
computer tomographic angiography (CTA). Both MRA
and CTA can reliably provide confirmatory evidence of the
presence of severe carotid artery stenosis, and can also
provide important supplemental information in the evalu-
ation of patients with cerebrovascular disease, particularly
with regard to the configuration of the aortic arch. How-
ever, it is important to note that CTA and MRA were not
used in the randomized, prospective trials comparing ca-
rotid endarterectomy (CEA) with medical management in
asymptomatic patients. Although studies have demon-
strated excellent correlation between these newer diagnos-
tic modalities and the conventional angiograms used in the
randomized trials, currently they are not the basis on which
most clinicians make clinical decisions regarding their pa-
tients. The mainstay of clinical decision-making with regard
to intervention for carotid artery stenosis remains the du-
plex scan, and for many practitioners this is often the sole
examination on which they make a decision to proceed with
carotid revascularization.
Recognizing the increasing dependence on duplex scan
flow measurements to make clinical decisions, and the need
to have a better understanding of the natural history of
individuals with asymptomatic carotid stenosis, we con-
ducted a retrospective review of patients with an end dia-
stolic velocity (EDV) between 100 to 124 cm/second at
the plaque in the internal carotid artery. Asymptomatic
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range may or may not be recommended to have CEA or
carotid artery stenting (CAS) depending on the correlation
of these measurements with angiographic criteria and the
philosophy of the clinician or center in selecting asymptom-
atic patients for intervention. Because of the uncertainty
regarding the correct management for individuals on the
border of moderate to severe asymptomatic carotid steno-
sis, we felt a follow-up study of individuals who fell within
these parameters was indicated.
PATIENTS AND METHODS
Permission to do this clinical study was obtained from
the New York University Institutional Review Board.
Commonly used duplex scan measurements include
the peak systolic velocity (PSV) at the narrowest portion of
the carotid plaque, the EDV at the narrowest portion of the
carotid plaque and the ratio of the PSV, and the PSV in the
mid common carotid artery. The vascular laboratory used is
an Intrasocietal Committee for Accrediting Vascular Lab-
oratories (ICAVL) accredited laboratory. Previous correla-
tion studies to obtain accreditation compared MRAs and
duplex scans in our laboratory. Based on these studies, we
established the following criteria for interpreting scan re-
sults: 50% to 79% stenosis if the PSV125 cm/second and
the EDV 125 cm/second; 80% to 99% stenosis if the
EDV125 cm/second. Knowing that others use the PSV,
the Internal Carotid Artery/Common Carotid Artery
(ICA/CCA) PSV ratio or a combination of criteria to
define 80% stenosis, in a separate study awaiting publica-
tion, we have examined the relationship among these vari-
ous measurements, irrespective of the actual measurements
on the MRA or other imaging modality. In that study, a
database of 12,875 scans was reviewed. Of 745 arteries with
an EDV 125 cm/second, 82.1% also had a PSV 350
cm/second (sensitivity 68.2%, specificity 99.4%, accuracy
98.2%). Conversely, of 897 arteries with a PSV 350
cm/second, only 68.2% had an EDV 125 cm/second. A
ratio of4.0 was present in 1977 of the scans, showing it to
be the least specific criterion.
For this study, the parameters for patient inclusion were
an EDV between 100 and 124 cm/second. Because we
generally would recommend carotid intervention for
asymptomatic patients with 80% stenosis provided they
were in good health, most individuals with an EDV 125
cm/second would have had a surgery and not be available
for a study focused on the natural history of carotid disease.
The lower parameter of 100 cm/second was chosen as
some recommend interventions for asymptomatic stenosis
for individuals with an EDV of 100 cm/second or greater.
In our correlation studies, we found no individuals with an
EDV100 cm/second who had an MRA or CTA showing
80% stenosis.
From a data bank of duplex scans, all individuals who
had at least one scan in the period from 2002 to 2007
demonstrating one or both of their carotid arteries to have
an EDV of 100 to 124 cm/second were identified. As the
laboratory is a part of our clinical practice, nearly all hadclinical files with demographics and clinical histories that
would be pertinent to cerebrovascular disease. The few
individuals sent to the laboratory only for diagnostic tests
were excluded from analysis as necessary clinical informa-
tion was not available.
We divided the patients into two groups, those who
were advised to have early CEA or CAS (30 days), and
those who were treated medically or advised that interven-
tion was not presently necessary. For those who had early
CEA or CAS, an effort was made to determine the reason
they were selected for intervention. For those who did not
have early intervention, follow-up evaluation consisted of
assessment of subsequent duplex scans and clinical infor-
mation from office and hospital records. For those not
recently evaluated, efforts were made to contact the pa-
tients for a follow-up duplex scan and clinic visit. When a
return to the clinic was not possible, clinical data from the
patient, the patient’s family members, or physician was used
to determine if the individual had sustained a transient
ischemic attack (TIA) or stroke, died, or had undergone
surgery elsewhere. Endpoints for this study were the devel-
opment of ipsilateral neurological symptoms (stroke and
TIA), progression of the ICA EDV to125 cm/second or
occlusion of the artery, carotid intervention, and death.
RESULTS
Of the 6735 carotid duplex scans performed in our
laboratory from 2002 through 2007, 144 patients were
identified as having an EDV of 100 to 124 cm/second.
One individual was found to have velocities of 100 to 124
cm/second in both carotid arteries. In all, there were 144
patients and 145 arteries identified for study. Of the 144
patients, 47 were advised to have early surgery. Thirty-eight
had surgery within 2 months of determining they had an
EDV of 124 cm/second. Six had surgery within 3 to 5
months. The remaining 3 patients had surgery delayed (7,
8, and 13 months) for various medical or personal reasons.
These were included in the early surgery group as it was the
intent to perform CEA or CAS. The remaining 97 patients
were initially advised not to have surgery and were placed
on medical therapy.
Of the 47 patients who had early procedures, a review
of their medical records was conducted to determine the
reason they were selected for intervention. Ten had ipsilat-
eral symptoms. Three had contralateral carotid artery oc-
clusion confirmed by MRA. Another 6, although below an
EDV of 125 cm/second, had demonstrated rapid progres-
sion in the degree of stenosis over serial studies leading to
the recommendation for intervention. The reason for in-
tervention in the remaining 28 patients was not always
clear, but letters to referring doctors mentioned related
issues including the appearance of the plaque on a CTA or
MRA (a more severe degree of stenosis than had been
recognized on the duplex scan, plaque irregularity, or deep
ulceration), the patient’s preference for early intervention,
young age, and low operative risk. Review of the final
duplex scans on these 28 patients revealed that all had a
ratio4.0 and/or a PSV300 cm/second, (18 had a PSV
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used duplex scan criteria for carotid intervention.. There
were no perioperative strokes or deaths resulting from the
interventions on these 47 individuals.
For the remaining 97 patients who did not undergo
early intervention, the follow-up ranged from 2 to 116
months with a mean of 29.1 months. If the patient had
been under observation before 2002, the follow-up was
calculated from the date the artery was first noted to have an
EDV100 cm/second. Additional follow-up duplex scans
were available on 82 of 97 patients. Clinical follow-up was
available on all 97 patients who did not have early interven-
tion. Demographics of these patients are shown in Table I.
Symptoms. Among the 97 patients who did not have
early CEA or CAS, 1 patient had an ipsilateral stroke 58
months after the initial duplex scan identifying him as EDV
100 to 124 cm/second. Another 4 patients had ipsilateral
TIAs (at 12, 17, and 2 at 54 months), two of which were
amaurosis fugax. Of note, 2 of these patients were being
followed at 6-month intervals and 3 at yearly intervals. In
all, there were five events in the 98 arteries available for
observation, with a risk of stroke or TIA of 5.1% over a
mean of 35.3 months of follow-up. Of these 5 patients who
developed ipsilateral symptoms, 3 were found to have
progressed to an EDV 125 cm/second. The other 2,
including the patient who had the stroke, remained within
the study range. An additional patient experienced nonfo-
cal symptoms which led to a surgical intervention. No
symptoms developed in the remaining 91 patients (Fig; and
Table I. Demographic and clinical data
Characteristics No. %
Male 51 52.6
Mean age (range) (at entry into study) 78.8 (53-92)
Smoking 28 (of 96) 29.2
Diabetes 18 18.6
Hypertension 60 61.9
Hyperlipidemia 39 (of 81) 48.1
0
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Fig. Life table for individuals free of progression and symptoms.Table II, online only).Progression. Progression of the plaque was defined as
a follow-up duplex scan showing an ICA EDV 124
cm/second or total occlusion of the internal carotid artery.
Of the 98 arteries available for study, 82 had at least one
additional duplex scan. Follow-up from the time of the first
duplex scan within the study criteria ranged from 2 to 58
months with a mean of 24 months. During observation, 24
arteries progressed beyond the ICA EDV of 125 cm/
second. An additional two were found to have occluded
their ICA. In all, 26 of 82 arteries (31.7%) had plaque
progression. Twelve patients were found to have pro-
gressed at the time of the next scan (2-26 months; mean 9.4
months). The remainder had 1 to 3 intervening scans
before progressing to an EDV 124 cm/second. As men-
tioned above, three of those who progressed also developed
symptoms. The remaining 23 arteries (28%) found to have
progressed (including the two total occlusions) did not
manifest any neurological symptoms (Fig; and Table II,
online only).
Surgical procedures. Thirty-five of the patients
(35.7%) underwent CEA or CAS during the follow-up
period. The interval between the first identification of an
ICA EDV 100 cm/second ranged from 2 to 58 months
with a mean of 18.5 months. The indication for surgery was
the development of focal ipsilateral symptoms (4), nonfocal
neurological symptoms (1), and progression to125 cm/
second (17). Another 13 patients had surgery without
symptoms or progression. Reasons for intervention in these
patients included progression to an EDV just below 125
cm/second, identification of ulceration or significant calci-
fication on an imaging study, and patient preference for
early intervention.
Deaths. Eight patients (8.2%) died during the period
of study. The mean period from the time they were first
found to have a stenosis within the study range to death was
38.3 months (range, 12-82 months). Only one of the
deaths was possibly attributed to cerebrovascular disease,
however, this could not be confirmed.
In all, 22 patients had surgery for either symptoms
and/or progression of the plaque. An additional 13 pa-
tients had surgery without symptoms or progression be-
yond an ICA EDV of 124 cm/second. In review of these
cases, 4 had PSVs400, another 5 had PSVs between 300
and 400. All but 3 patients had ratios 4.0. Some individ-
uals had MRAs or CTAs that led to the recommendation
for surgery. Six patients who did not have surgery pro-
gressed to an EDV above 125 cm/second, or occluded
their ICA. The remaining 56 of the 97 patients (57.7%) did
not reach a surgical, symptomatic, or progression endpoint.
Eight of the 56 patients died of natural causes. By life table
analysis, the risk of TIA or stroke was 3% and the risk of
progression was 25.7% at 36 months (Fig; and Table II,
online only).
DISCUSSION
Although the ACAS report was to have settled the role
of surgical vs medical treatment, controversies surrounding
the management of asymptomatic carotid stenosis are as
Caro
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and interventionalists point to ACAS as the definitive study
establishing the benefit of CEA for asymptomatic carotid
disease and use the data to support surgical procedures on
asymptomatic individuals with as little as 60% stenosis of a
carotid artery. Others more critical of CEA and CAS argue
that the benefit of surgery was very small (5.5% vs 11% risk
of stroke at 5 years) and point out that as many as 20
individuals will undergo surgery to prevent a single stroke.
Added to their argument is the suggestion that current
medical therapy is far superior to what it was 20 years ago.
Some go so far to say that had the medically treated group
received today’s standard of care, the margin of benefit for
surgery would have been less or perhaps none at all.3,4
Although the ACAS report concludes that surgery is
beneficial for asymptomatic patients with 60% stenosis,
many clinicians feel that there is a higher risk of stroke for
medically treated patients with more severe degrees of
stenosis than with those at the lower end of the 60% to 99%
spectrum. In the NASCET trial, which focused on individ-
uals with prior strokes or TIAs, there was a direct correla-
tion between the degree of stenosis and the risk of future
stroke in nonoperated patients.1 Moreover, natural history
studies before ACAS showed a significant risk of stroke for
individuals with 80% stenosis.5 Conversely, studies of
asymptomatic individuals with less than 80% stenosis have
been shown to have a relatively low risk of stroke.6
It has been suggested that the reason ACAS failed to
show a correlation between the degree of stenosis and the
risk of stroke in the medical treatment arm was the paucity
of individuals with truly high-grade stenosis (80%) in the
study. In fact, among those who had conventional angio-
grams, only 30% had 80% stenosis, and only 5% had
90% stenosis. In addition, as there were a large number of
crossover patients (patients initially randomized to medical
treatment who were ultimately treated with surgery), it is
likely that the numbers of individuals with severe stenosis
80% followed with medical treatment alone were even
less. In close examination of the Asymptomatic Carotid
Surgery Trial, the European study addressing asymptom-
atic carotid stenosis, it seems that a similar recruitment bias
Table III. Studies comparing duplex criteria with angiogr
Author Degree stenosis PSV cm/sec E
AbuRahma8 70% 150 and 110
Back9 75% 125
Carpenter10 70% 210
Faught11 70% 130 plus 100
Filis12 80% 330
Monetta13 70%
Shaalan14 80% 320
80%
80%
EDV, End diastolic velocity; ICA/CCA, Internal Carotid Artery/Commonmay have occurred.7 Taking into account these issues, andrecognizing that the overall benefit of carotid revasculariza-
tion in an individual asymptomatic patient may not be
dramatic, many clinicians have chosen to be relatively con-
servative in recommending CEA for asymptomatic pa-
tients. This has translated in many instances into a recom-
mendation for treating asymptomatic patients with CEA
only when the degree of stenosis has reached 80%, as
opposed to the ACAS recommended 60%. This issue cre-
ates even more confusion given the fact that there are no
universally defined or accepted duplex scan criteria for
predicting a “severe” stenosis, and that several different
methods have been used to measure the degree of stenosis
even using arteriography. Ultimately, each vascular labora-
tory performing duplex scans must validate its own criteria,
and clinicians need to be aware of the source of the duplex
scan report, and examine the raw velocity parameters as
opposed to simply accepting a description of “moderate”
or “severe.”
In recent years, duplex ultrasonography has become
the diagnostic procedure of choice for the evaluation of
carotid artery disease. The simplicity and safety of duplex
scanning has made it an excellent means of screening indi-
viduals suspected of having carotid bifurcation disease, and
many clinicians now use duplex scans as the principal means
of selecting patients for CEA or CAS. Reliance on duplex
scans for clinical decisions is acceptable if the flow velocity
criteria correlate well with the degree of stenosis one would
measure on a conventional angiogram. Unfortunately,
there are no universally established criteria for interpreting
duplex scans of the carotid artery (Table II). Recognizing
the difficulty in establishing standard criteria for interpret-
ing duplex scan results, ICAVL has recommended that
each laboratory perform their own validation tests. Unfor-
tunately, few vascular laboratories have sufficient numbers
of conventional angiograms required to perform their own
validation tests, so that most rely on recommended criteria
to establish parameters for various degrees of stenosis at the
arotid bifurcation (Table III).
Despite the difficulty in agreeing upon duplex criteria
which correlate with the angiographic measurements used
in NASCET and ACAS, it is doubtful that any future
c measurements
/sec ICA/CCA ratio Sensitivity % Specificity %
85 95
4.0 90 74
94 77
0 92 60
3.0 91 78
81 98
0 3.8 98
4.0 91 87
87 90
0 84 91
6.0 82 91
tid Artery Ratio; PSV, peak systolic velocity.aphi
DV cm
7
13
14carotid studies will be based on the strict measurements as
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Trial I accepts an EDV100 cm/second as the criteria for
entry to be randomized into treatment by CEA or CAS.
This raises two questions. First, are the selection criteria less
stringent (more inclusive) than those used in ACAS? Sec-
ond, without a medical treatment arm to show the risk of
stroke without either intervention, are the procedures be-
ing performed on many individuals who are at negligible
risk for stroke? The data from this study, although small and
uncontrolled, suggest that below an EDV of 125 cm/
second the risk of stroke is very small (1%/year). On the
other hand, in our study, 29 of 98 arteries (29.9%) that
were followed either progressed or became symptomatic in
follow-up. Whether the risk of progression added to the
risk of symptoms justifies earlier intervention is debatable.
Certainly, with the improvement of medical therapy,
there is a need for a better understanding of asymptomatic
carotid disease. Cerebral angiography can no longer be
justified as a means of classifying individuals to be entered
into clinical trials, particularly if they are to be assigned to
medical treatment. MRAs and CTAs have greatly improved
in accuracy in showing the residual lumen, but both have
limitations. For these reasons, the time-honored conven-
tion of classifying individuals according to the diameter
reduction of the lumen may be impractical in today’s prac-
tice. Clearly we need improved criteria for selecting patients
for study and for categorizing them into risk groups.
In as much as duplex scans are widely used for clinical
assessment, particularly for individuals being managed with
medical therapy, it may be appropriate to establish duplex
criteria for future studies. We feel that the EDV is useful for
this purpose as it is reproducible, more specific relative to
the PSV and ICA/CCA ratio, and easily measured on most
currently used duplex scanners.
In conclusion, based on this retrospective study, we
find the risk of stroke for initially asymptomatic individuals
with an EDV 125 cm/second is small (1%/year), and,
therefore, any intervention that carries 1% risk must be
justified on the basis of other criteria and carefully weighed
in terms of benefit to the patient, with a particular focus on
comorbidities and the patient’s expected longevity.
Second, individuals with an EDV between 100 and 124
cm/second have a high probability of progression to125
cm/second, and presumably a greater degree of stenosis.
Careful follow-up with duplex scans every 6 months is
warranted assuming one would recommend intervention
for a severe stenosis.
Third, in as much as conventional angiograms are no
longer used for diagnostic purposes, categorization of pa-
tients by flow velocity criteria rather than diameter reduc-
tion measurements may be more suitable to today’s clinical
practice. Each laboratory should conduct validation studies
to determine which criteria best correlate with the
NASCET angiographic measurements that served to define
risks for various groups of our patients. In our experience,
the EDV has been the most reproducible and the most
specific criteria for classifying and comparing individuals,but future studies may find better measurements to catego-
rize patients.
Fourth, this study focused on the clinical course of a
particular subset of individuals for whom there has been
uncertainty regarding the role of CEA and/or CAS. It is
limited in that it is a retrospective study and the choices to
either operate or observe patients were in many cases arbi-
trary and not clear from the clinical records. The selection
process for those who underwent early CEA or CAS could
have significantly biased the group not offered early inter-
vention who served as the basis for the natural history
study. Nonetheless, we feel the data collected from the 97
patients who did not have early intervention adds new
information to our understanding of patients with moder-
ate to severe asymptomatic carotid artery disease. We are
hopeful that this report will lead not only to larger prospec-
tive studies of patients in this category, but also to more
natural history studies of individuals with asymptomatic
carotid stenosis above and below our range of an EDV of
100 to 124 cm/second.
Last, although in ACAS, unlike NASCET, the risk of
future stroke was the same for individuals with 60% stenosis
or 90% stenosis, the paucity of individuals with severe
stenosis in the ACAS study challenges that conclusion. We
suggest that future studies addressing the natural history or
medical treatment for asymptomatic carotid artery stenosis
not only include the flow velocities of the individuals, but
also use duplex criteria to divide them into subcategories
according to the severity of the stenosis. This will both help
investigators to better compare patient populations, but
also to give us new information regarding the relative risk
for individuals with varying degrees of carotid stenosis.
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analysis with regard to freedom from progression,
symptoms, and combined outcome of progression
and symptoms.
Freedom from progression
Time
(mo)
Cumulative
proportion
surviving at time No. of
cumulative
events
No. of
remaining
casesEstimate SE
3 .980 .014 2 96
6 .949 .022 5 90
12 .893 .032 10 74
18 .837 .040 14 56
24 .743 .051 20 46
36 .701 .056 22 33
48 .678 .059 23 21
60 23 9
72 23 3
84 23 1
Freedom from symptoms
Time
(mo)
Cumulative
proportion
surviving No. of
cumulative
events
No. of
remaining
casesEstimate SE
12 .987 .013 1 74
18 .970 .021 2 57
24 2 46
36 2 34
48 2 22
60 .862 .074 4 16
72 .796 .094 5 12
84 .796 .094 5 1
Freedom from progression and symptoms
Time
(mo)
Cumulative
proportion
surviving No. of
cumulative
events
No. of
remaining
casesEstimate SE
3 .980 .014 3 95
6 .949 .022 5 90
12 .881 .034 11 73
18 .812 .043 16 57
24 .752 .049 20 48
36 .679 .057 24 33
48 .657 .059 25 22
